Insider trades
Todd Harris, CEO of Tyra Biosciences TYRA, has filed 0 purchases and 43 sales on the open market. The latest trade was on 05/05.
Todd Harris
President and CEO
- Company
- Tyra Biosciences TYRA
- First filing
- 23/03/17
- Trades
- 78 trades
- Buys / sales
- 0 / 43
- 12-month net buying
- No record
- Last trade
- 05/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
TYRA | Open-market sale10b5-1 plan | 24/10/18–24/10/21 | 24/10/22 | 62,720 sh3 trades | $27.28avg. | $1,711,061.16 | −4.4% |
TYRA | Open-market sale10b5-1 plan | 24/10/15–24/10/17 | 24/10/17 | 58,726 sh6 trades | $25.77avg. | $1,513,210.62 | −4.0% |
Tyra BiosciencesTYRA | Open-market sale10b5-1 plan | 24/09/30 | 24/10/02 | 500 sh | $24.00 | $12,000 | −0.0% |
TYRA | Open-market sale10b5-1 plan | 24/09/23–24/09/25 | 24/09/25 | 11,747 sh3 trades | $24.11avg. | $283,267.06 | −0.8% |
TYRA | Open-market sale10b5-1 plan | 24/09/18–24/09/20 | 24/09/20 | 16,307 sh4 trades | $24.19avg. | $394,449.71 | −1.1% |
TYRA | Open-market sale10b5-1 plan | 24/02/02–24/02/05 | 24/02/06 | 100,000 sh3 trades | $16.56avg. | $1,656,425.17 | −6.2% |
TYRA | Open-market sale10b5-1 plan | 23/06/22–23/06/23 | 23/06/26 | 24,190 sh4 trades | $17.01avg. | $411,539.93 | −1.5% |
TYRA | Open-market sale10b5-1 plan | 23/06/16–23/06/21 | 23/06/21 | 75,810 sh7 trades | $17.12avg. | $1,297,601.77 | −4.5% |
TYRA | Open-market sale10b5-1 plan | 23/06/13–23/06/15 | 23/06/15 | 20,700 sh2 trades | $16.08avg. | $332,860.49 | −1.2% |
Tyra BiosciencesTYRA | Open-market sale10b5-1 plan | 23/04/03 | 23/04/05 | 2,000 sh | $16.13 | $32,260 | −0.1% |
TYRA | Open-market sale | 23/03/29–23/03/31 | 23/03/31 | 4,327 sh3 trades | $16.08avg. | $69,560.74 | −0.3% |
TYRA | Open-market sale | 23/03/24–23/03/28 | 23/03/28 | 5,912 sh3 trades | $16.00avg. | $94,592 | −0.3% |
TYRA | Open-market sale | 23/03/21–23/03/23 | 23/03/23 | 19,236 sh3 trades | $16.00avg. | $307,776 | −1.1% |